Nigeria commenced vaccination with the Oxford vaccines last Friday with Cyprian Ngong, a medical doctor becoming the first person to receive a jab in Nigeria. The rollout started with healthcare workers who are often at the risk of exposure to infections being the first responders to patients.

Chairman, Presidential Task Force (PTF) on COVID-19, Boss Mustapha, said Monday at a media briefing in Abuja said that he was leading all members of the PTF to receive the first doses of the vaccine as a further demonstration of the safety and efficacy.

“Let me underscore at this point that in this war, we are all involved in this because nobody is safe until everybody is safe. Our ultimate objective is to vaccinate about 70 per cent of our population which is about 200 million, between year 2021 and 2022,” he said.

Reacting to apathy and hesitancy over COVID-19 vaccines, Mustapha said: “Nigerians should never allow vaccine hesitancy propagated through conspiracy theories sway you from the path of doing the right thing. Taking the vaccines will protect you, your loved ones and the entire community. I similarly wish to warn against patronizing unauthorized vaccines peddlers. The only recognised safe and efficacious vaccines are those coming through the National Primary Health Care Development Agency (NPHCDA). We should remain vigilant.”

Mustapha, Minister of Health, Dr Osagie Ehanire and his Information and Culture counterpart, Alhaji Lai Mohammed, among other members of the task force yesterday received their first dose of Oxford AstraZeneca vaccine.

Others were the Minister of Environment, Muhammad Mahmood; Minister of State for Health, Olorunnimbe Mamora; Director-General of Nigeria Centre for Disease Control (NCDC), Chikwe Ihekweazu; Minister of Foreign Affairs, Geoffrey Onyeoma, and the National Incident Manager, PTF, Mukhtar Muhammad, among others.

Also, four journalists who are considered part of the critical front-liners in the fight against the virus received the vaccine in a representative manner. They were Friday Okoregbe, Channels Television; Hassan Umar Faruk, Liberty Television; Nancy Oyediya Urum, Africa Independent Television (AIT); and Rahila Lassa, Voice of Nigeria (VON).

The vaccines were administered by Obuba Horsefall, the supervising nurse, Adaga Lucy and Obodia Ogonna, after which each of them was issued a vaccination card showing they have received the first dose of the vaccine and when they will receive the second dose.

This is coming after President Muhammadu Buhari’s Chief of Staff, Prof Ibrahim Gambari yesterday received the Oxford/AstraZeneca COVID-19 vaccine. The public vaccination, officials say, is to reassure Nigerians and douse skepticisms about the safety and efficacy of the vaccines.

Gambari was given the jab after e-registration and filling of their vaccination card. He sat for 15 minutes as prescribed by the vaccination routine. The Chief of Staff was thereafter presented with vaccination card by the Chief Medical Director of the State House Medical Centre, Dr Husain Munir.

In his remarks, Gambari said the vaccination was painless and that he followed the footsteps of President Buhari, who demonstrated leadership alongside his deputy to receive the jabs on Saturday. He advised eligible Nigerians to take the vaccines, assuring that it is safe.

The government had on Saturday hinted that getting COVID-19 vaccination could become a requirement for all international passengers as the fight against the killer infection continues to gain steam.

Meanwhile, the Presidential Taskforce on COVID-19 has made adequate provisions to deploy the vaccines to all states and vaccination sites where people will be vaccinated according to set priorities beginning with the frontline health workers and other support staff.

The state launch of the vaccination for frontline health workers will begin today at the state treatment centres while many governors have agreed to flag off vaccination tomorrow, Wednesday, just as the roll out for the general public will commence from March 12, barring any change.

Executive Director of the National Primary Healthcare Development Agency (NPHCDA), Dr Faisal Shuaib, said government is working with CACOVID to ensure that the vaccines are airlifted to the states in time for the roll out.

He noted that it is expected that the states will roll out vaccination only when local governments have met the minimum criteria for successful conduct of the campaign, such as training, cold chain status, proposition of data tools, availability of transport logistics for healthcare workers, and adequate security for vaccines.

The Federal Office for Safety in Health Care (BASG) said a 49-year-old woman died as a result of severe coagulation disorders. It also confirmed another 35-year-old woman developed a pulmonary embolism and is now recovering.

BASG, however, said: “Currently there is no evidence of a causal relationship with the vaccination.”Swiss newspaper Niederoesterreichische Nachrichten as well as broadcaster ORF and the APA news agency reported that the women were both nurses who worked at the Zwettl clinic.

BASG said blood clotting was not among the known side effects of the vaccine and confirmed it was pursuing its investigation vigorously to completely rule out any possible link.

It noted the vaccine had been approved by the European Medicines Agency and the World Health Organisation (WHO) based on a global clinical programme involving 23,000 participants.

This is coming two months after South Africa rejected about 1.5 million doses of the same vaccine after evidence emerged that the vaccine did not protect clinical-trial participants from mild or moderate illness caused by the more contagious virus variant that was first seen in the country.

Apart from the concerns raised in Austria and South Africa, preliminary results from a trial of the vaccines are not clear and did not reflect data from older people, the New York Times reported.

Furthermore, concerns about the efficacy of the AstraZeneca vaccine have also hampered its rollout in Italy, with some refusing to have the jab as they believe the Pfizer or Moderna vaccines offer more protection.